These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18347258)

  • 21. Histological Changes of the Middle Ear Ossicles Harvested during Cholesteatoma Surgery.
    Školoudík L; Šimáková E; Kalfeřt D; Chrobok V
    Acta Medica (Hradec Kralove); 2015; 58(4):119-22. PubMed ID: 26960823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of preoperative findings and ossicular discontinuity in chronic otitis media.
    Jeng FC; Tsai MH; Brown CJ
    Otol Neurotol; 2003 Jan; 24(1):29-32. PubMed ID: 12544024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of epidermal differentiation in middle ear cholesteatoma.
    Stammberger M; Bujía J; Kastenbauer E
    Am J Otol; 1995 Jul; 16(4):527-31. PubMed ID: 8588655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression and significance of PDK1 and NF-κB in the middle ear cholesteatoma].
    Du L; Xie YD; Liu M
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(10):770-773. PubMed ID: 29798050
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical and pathological features of cholesteatoma in young children].
    Skotnicka B; Hassmann-Poznańska E
    Otolaryngol Pol; 2010; 64(6):375-81. PubMed ID: 21302505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
    Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
    Shinoda H; Huang CC
    Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
    Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Terminal differentiation and mitogen-activated protein kinase signaling in human cholesteatoma epithelium.
    Huisman MA; De Heer E; Grote JJ
    Otol Neurotol; 2006 Apr; 27(3):422-6. PubMed ID: 16639284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keratinocyte growth factor and its receptor expression in chronic otitis media with and without cholesteatoma.
    Harabagiu OE; Cosgarea M; Mogoantă CA; Leucuţa DC; Maniu AA
    Rom J Morphol Embryol; 2017; 58(4):1333-1338. PubMed ID: 29556625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
    Holly A; Sittinger M; Bujia J
    Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autograft ossiculoplasty in cholesteatoma surgery: a histological study.
    Attanasio G; Gaudio E; Mammola CL; Cagnoni L; De Seta D; Minni A; Covelli E; Filipo R
    Acta Otolaryngol; 2014 Oct; 134(10):1029-33. PubMed ID: 25220725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R; Welkoborsky HJ; Mann W
    Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caspase-3, caspase-8, and nuclear factor-kappaB expression in human cholesteatoma.
    Miyao M; Shinoda H; Takahashi S
    Otol Neurotol; 2006 Jan; 27(1):8-13. PubMed ID: 16371840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
    Raynov AM; Moon SK; Choung YH; Hong SP; Park K
    Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression and significance of nuclear factor-kappa B ligand and correlation factor in the tissue of otitis media with cholesteatoma].
    Xia M; Ding S; Zhang H; Liu F; Yin H; Xu A
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Apr; 21(7):315-7. PubMed ID: 17580719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The research progress of keratin's roles in the pathology of middle ear cholesteatoma].
    Feng YS; Si Y; Zhang ZG
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Nov; 54(11):870-874. PubMed ID: 31795552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopy-Assisted Ear Surgery for Treatment of Chronic Otitis Media With Cholesteatoma, Adhesion, or Retraction Pockets.
    Ulku CH
    J Craniofac Surg; 2017 Jun; 28(4):1017-1020. PubMed ID: 28277483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.